Innovation and Growing Demand for Nuclear Medicine Drives Curium Expansion and 10-Year Commitment to St. Louis, MO
Renaissance in nuclear medicine to attract top St. Louis talent
- Renaissance in nuclear medicine to attract top St. Louis talent
ST. LOUIS, March 02, 2023 (GLOBE NEWSWIRE) -- Curium, the world’s leading nuclear medicine company, announced today the expansion of its North America Headquarters in St. Louis. - Each week, Curium’s Maryland Heights, MO manufacturing facility produces and ships thousands of doses of nuclear medicine products that help doctors diagnose disease and evaluate organ function.
- Michael Patterson, Curium North America CEO commented: “With a renaissance underway in nuclear medicine, investment, innovation, and growth is at unprecedented levels.
- Curium’s mission is to redefine the experience of cancer through our trusted legacy in nuclear medicine – developing new tools to both diagnose and treat cancer.